IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,591 | +10.6% | 476 | 0.0% | 0.02% | +5.6% |
| Q2 2023 | $19,530 | +14.8% | 476 | 0.0% | 0.02% | +12.5% |
| Q1 2023 | $17,012 | +94411.1% | 476 | 0.0% | 0.02% | -5.9% |
| Q4 2022 | $18 | -99.9% | 476 | 0.0% | 0.02% | -15.0% |
| Q3 2022 | $21,000 | +16.7% | 476 | 0.0% | 0.02% | +25.0% |
| Q2 2022 | $18,000 | 0.0% | 476 | 0.0% | 0.02% | +23.1% |
| Q1 2022 | $18,000 | – | 476 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |